Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Colorado, Denver

About this trial

The goal of this intervention study is to learn about how weight loss impacts molecular signaling of intermuscular adipose tissue (IMAT) in individuals with obesity. The main question it aims to answer is how inflammatory molecules secreted by IMAT promote muscle insulin resistance and inflammation, and how these same molecules are diminished after weight loss. Following screening visits involving body composition measures, blood testing, strength testing, and a thigh muscle biopsy, participants will go through a 12-week dietary intervention for weight loss. After 12 weeks, this will be followed by the same testing and biopsies that were completed before the intervention. Researchers will then compare outcomes of individuals who lost weight to individuals who did not lose weight.

Eligibility criteria

Qualifiers

Generally healthy men and women aged 18-70

BMI between 30-40

Less than 1 hour of exercise per week

may be pre or post menopausal

Disqualifiers

Type 1 or Type 2 diabetes

Thyroid disease

History of lung disease

Active use of nicotine

Trial design

Treatments tested in this trial

  • Diet Weight Loss

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator